Allosteric inhibition of carnosinase (CN1) by inducing a conformational shift

References

• Teufel M, Saudek V, Ledig JP, et al. Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. J Biol Chem 2003;278:6251–531.
   PubMed Web of Science ®Google Scholar
• Janssen B, Hohenadel D, Brinkkoetter P, et al. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 2005;54:2320–7.
   PubMed Web of Science ®Google Scholar
• Mooyaart AL, Zutinic A, Bakker SJ, et al. Association between CNDP1 genotype and diabetic nephropathy is sex specific. Diabetes 2010;59:1555–9.
   PubMed Web of Science ®Google Scholar
• Barski OA, Xie Z, Baba SP, et al. Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2013;33:1162–70.
   PubMed Web of Science ®Google Scholar
• Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol 2008;153:6–20.
   PubMed Web of Science ®Google Scholar
• Vistoli G, Orioli M, Pedretti A, et al. Design, synthesis, and evaluation of carnosine derivatives as selective and efficient sequestering agents of cytotoxic reactive carbonyl species. ChemMedChem 2009;4:967–75.
   PubMed Web of Science ®Google Scholar
• Alhamdani M, Al-Azzawie HF, Abbas FK. Decreased formation of advanced glycation end-products in peritoneal fluid by carnosine and related peptides. Perit Dial Int 2007;27:86–9.
   PubMed Web of Science ®Google Scholar
• Hou W, Chen HJ, Lin YH. Antioxidant peptides with angiotensin converting enzyme inhibitory activities and applications for angiotensin converting enzyme purification. J Agric Food Chem 2003;51:1706–9.
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Ueno A, Nishikawa Y. Interactions between carnosine and captopril on free radical scavenging activity and angiotensin-converting enzyme activity in vitro. Yakugaku Zasshi: J Pharm Soc Japan 2006;126:37–42.
   PubMed Web of Science ®Google Scholar
• Babizhayev MA, Lankin VZ, Savel’Yeva EL, et al. Diabetes mellitus: novel insights, analysis and interpretation of pathophysiology and complications management with imidazole-containing peptidomimetic antioxidants. Recent Pat Drug Deliv Formul 2013;7:216–56.
   PubMedGoogle Scholar
• Decker E, Livisay SA, Zhou S. A re-evaluation of the antioxidant activity of purified carnosine. Biochem Mosc 2000;65:766–70.
   PubMed Web of Science ®Google Scholar
• Hipkiss AR. Energy metabolism, proteotoxic stress and age-related dysfunction – protection by carnosine. Mol Aspects Med 2011;32:267–78.
   PubMed Web of Science ®Google Scholar
• Mozdan M, Szemraj J, Rysz J, Nowak D. Antioxidant properties of carnosine re-evaluated with oxidizing systems involving iron and copper ions. Basic Clin Pharmacol Toxicol 2005;96:352–60.
   PubMed Web of Science ®Google Scholar
• Velez S, Nair NG, Reddy VP. Transition metal ion binding studies of carnosine and histidine: biologically relevant antioxidants. Colloids Surf B Biointerfaces 2008;66:291–4.
   PubMed Web of Science ®Google Scholar
• Aydogan S, Yapislar H, Artis S, Aydogan B. Impaired erythrocytes deformability in H(2)O(2)-induced oxidative stress: protective effect of l-carnosine. Clin Hemorheol Microcirc 2008;39:93–8.
   PubMed Web of Science ®Google Scholar
• Hipkiss A. Carnosine, a protective, anti-ageing peptide? Int J Biochem Cell Biol 1998;30:863–86.
   PubMed Web of Science ®Google Scholar
• McFarland G, Holliday R. Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res 1994;212:167–75.
   PubMed Web of Science ®Google Scholar
• Boldyrev AA, Aldini G, Derave W. Physiology and pathophysiology of carnosine. Physiol Rev 2013;93:1803–45.
   PubMed Web of Science ®Google Scholar
• Baguet A, Everaert I, Yard B, et al. Does low serum carnosinase activity favor high-intensity exercise capacity? J Appl Physiol (Bethesda, Md: 1985) 2014;116:553–9.
   Web of Science ®Google Scholar
• Vistoli G, Carini M, Aldini G. Transforming dietary peptides in promising lead compounds: the case of bioavailable carnosine analogs. Amino Acids 2012;43:111–26.
   PubMed Web of Science ®Google Scholar
• Peters V, Schmitt CP, Zschocke J, et al. Carnosine treatment largely prevents alterations of renal carnosine metabolism in diabetic mice. Amino Acids 2012;42:2411–16.
   PubMed Web of Science ®Google Scholar
• Ansurudeen I, Sunkari VG, Grunler J, et al. Carnosine enhances diabetic wound healing in the db/db mouse model of type 2 diabetes. Amino Acids 2012;43:127–34.
   PubMed Web of Science ®Google Scholar
• Forsberg EA, Botusan IR, Wang J, et al. Carnosine decreases IGFBP1 production in db/db mice through suppression of HIF-1. J Endocrinol 2015;225:159–67.
   PubMed Web of Science ®Google Scholar
• Riedl E, Pfister F, Braunagel M, et al. Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats. Cell Physiol Biochem 2011;28:279–88.
   PubMed Web of Science ®Google Scholar
• Peters V, Riedl E, Braunagel M, et al. Carnosine treatment in combination with ACE inhibition in diabetic rats. Regul Pept 2014;194-195:36–40.
   Google Scholar
• Pfister F, Riedl E, Wang Q, et al. Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy. Cell Physiol Biochem 2011;28:125–36.
   PubMed Web of Science ®Google Scholar
• Peters V, Kebbewar M, Jansen EW, et al. Relevance of allosteric conformations and homocarnosine concentration on carnosinase activity. Amino Acids 2010;38:1607–15.
   PubMed Web of Science ®Google Scholar
• Pavlin M, Rossetti G, De Vivo M, Carloni P. Carnosine and homocarnosine degradation mechanisms by the human carnosinase enzyme CN1: insights from multiscale simulations. Biochemistry 2016;55:2772–84.
   PubMed Web of Science ®Google Scholar
• Bando K, Shimotsuji T, Toyoshima H, et al. Fluorometric assay of human serum carnosinase activity in normal children, adults and patients with myopathy. Ann Clin Biochem 1984;21: 510–14.
   PubMed Web of Science ®Google Scholar
• Lindner HA, Lunin VV, Alary A, et al. Essential roles of zinc ligation and enzyme dimerization for catalysis in the aminoacylase-1/M20 family. J Biol Chem 2003;278:44496–504.
   PubMed Web of Science ®Google Scholar
• Peters V, Jansen EE, Jakobs C, et al. Anserine inhibits carnosine degradation but in human serum carnosinase (CN1) is not correlated with histidine dipeptide concentration. Clin Chim Acta 2011;412:263–7.
   PubMed Web of Science ®Google Scholar
• Peters V, Lanthaler B, Amberger A, et al. Carnosine metabolism in diabetes is altered by reactive metabolites. Amino Acids 2015;47:2367–76.
   PubMed Web of Science ®Google Scholar
• Sanchez-Gomez FJ, Espinosa-Diez C, Dubey M, et al. S-glutathionylation: relevance in diabetes and potential role as a biomarker. Biol Chem 2013;394:1263–80.
   PubMed Web of Science ®Google Scholar
• Calabrese V, Cornelius C, Leso V, et al. Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochim Biophys Acta 2012;1822:729–36.
   PubMed Web of Science ®Google Scholar
• Vistoli G, Pedretti A, Cattaneo M, et al. Homology modeling of human serum carnosinase, a potential medicinal target, and MD simulations of its allosteric activation by citrate. J Med Chem 2006;49:3269–77.
   PubMed Web of Science ®Google Scholar
• Vistoli G, Colzani M, Mazzolari A, et al. Computational approaches in the rational design of improved carbonyl quenchers: focus on histidine containing dipeptides. Future Med Chem 2016;8:1721–37.
   PubMed Web of Science ®Google Scholar
• Korb O, Stutzle T, Exner TE. Empirical scoring functions for advanced protein-ligand docking with PLANTS. J Chem Inf Model 2009;49:84–96.
   PubMed Web of Science ®Google Scholar
• Pedretti A, Villa L, Vistoli G. VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs. J Mol Graph Model 2002;21:47–9.
   PubMed Web of Science ®Google Scholar
• Phillips JC, Braun R, Wang W, et al. Scalable molecular dynamics with NAMD. J Comput Chem 2005;26:1781–802.
   PubMed Web of Science ®Google Scholar
• Gaunitz F, Hipkiss AR. Carnosine and cancer: a perspective. Amino Acids 2012;43:135–42.
   PubMed Web of Science ®Google Scholar
• Herculano B, Tamura M, Ohba A, et al. Beta-alanyl-L-histidine rescues cognitive deficits caused by feeding a high fat diet in a transgenic mouse model of Alzheimer’s disease. J Alzheimers Dis 2013;33:983–97.
   PubMed Web of Science ®Google Scholar
• Hipkiss AR. Aging risk factors and Parkinson’s disease: contrasting roles of common dietary constituents. Neurobiol Aging 2014;35:1469–72.
   PubMed Web of Science ®Google Scholar
• Mong MC, Chao CY, Yin MC. Histidine and carnosine alleviated hepatic steatosis in mice consumed high saturated fat diet. Eur J Pharmacol 2011;653:82–8.
   PubMed Web of Science ®Google Scholar
• Turell L, Radi R, Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med 2013;65:244–53.
   PubMed Web of Science ®Google Scholar
• Rossi R, Giustarini D, Milzani A, Dalle-Donne I. Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings. J Cell Mol Med 2009;13:3131–40.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Khan H, Shahab U, et al. Protein oxidation: an overview of metabolism of sulphur containing amino acid, cysteine. Front Biosci (Schol Ed) 2017;9:71–87.
   PubMedGoogle Scholar
• Gu L, Robinson RA. Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases. Proteomics Clin Appl 2016;10:1159–77.
   PubMed Web of Science ®Google Scholar
• Chauvin JR, Pratt DA. On the reactions of thiols, sulfenic acids, and sulfinic acids with hydrogen peroxide. Angew Chem Int Ed Engl 2017;56:6255–9.
   Google Scholar
• Chaleckis R, Murakami I, Takada J, et al. Individual variability in human blood metabolites identifies age-related differences. Proc Natl Acad Sci USA 2016;113:4252–9.
   PubMed Web of Science ®Google Scholar
• Auclair JR, Brodkin HR, D’Aquino JA, et al. Structural consequences of cysteinylation of Cu/Zn-superoxide dismutase. Biochemistry 2013;52:6145–50.
   PubMed Web of Science ®Google Scholar
• Melancon BJ, Hopkins CR, Wood MR, et al. Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery. J Med Chem 2012;55:1445–64.
   PubMed Web of Science ®Google Scholar
• Wootten D, Christopoulos A, Sexton PM. Emerging paradigms in GPCR allostery: implications for drug discovery. Nat Rev Drug Discov 2013;12:630–44.
   PubMed Web of Science ®Google Scholar